Achieve Life Sciences (ACHV US)

Analysis

Health Care • United States

Achieve Life Sciences, Inc. operates as a pharmaceutical company. The Company develops and commercializes cytisine treatment to help people battling nicotine addiction. Achieve Life Sciences serves customers in North America.

Refresh

Company Event • 13 Mar 2026 21:30 • Upcoming

Add To Calendar

Q4 2025

Company Event • 06 Nov 2025 21:30 • Latest

Q3 2025

Company Event • 05 Nov 2025 20:00 • Upcoming

Add To Calendar

Corporate Presentation

Company Event • 07 Aug 2025 20:30

Q2 2025

Company Event • 07 Aug 2025 06:00 • Upcoming

Add To Calendar

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00